EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection

Yuto Igarashi iD, Mayu Shimokawa iD, Kunio Kawanishi iD, Toshihito Hirai iD, Hiroshi Seino iD, Tomokazu Shimizu iD, Hideki Ishida iD, Toshio Takagi iD

Histopathology · 2026-08 · 89 (2) · 372-382

DOI: 10.1111/his.70162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 21.04.2026. Verfasst von Yuto Igarashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Graft Rejection, Complement C4b, Kidney Transplantation, Kidney Glomerulus. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Chronic active antibody‐mediated rejection (caABMR) is a major cause of late kidney allograft failure, yet reliable histological indicators of microvascular injury and therapeutic response remain insufficient. Complement C4d deposition reflects complement activation but does not fully capture endothelial remodelling, particularly in ABO‐incompatible transplantation. Plasmalemma vesicle‐associated protein‐1 (PV‐1), encoded by PLVAP and normally absent from glomerular endothelium, is upregulated during endothelial remodelling. We investigated whether glomerular PV‐1 complements C4d in identifying active endothelial injury in caABMR. Methods and results A total of 429 allograft biopsies from 126 patients with caABMR and 345 surveillance biopsies from 94 stable recipients were analysed. Glomerular PV‐1 and C4d immunofluorescence intensities were quantified and correlated with histopathological lesions, renal function, and donor‐specific antibodies, with stratification by ABO compatibility. Both PV‐1 and C4d were associated with microvascular inflammation and transplant glomerulopathy. While C4d reflected cumulative complement activation and showed staining in ABO‐incompatible grafts, PV‐1 specifically identified endothelial remodelling, particularly in lesions with double‐contour formation, and demonstrated dynamic reduction following B‐cell‐directed therapy. Low‐vacuum scanning electron microscopy correlated with the presence of de novo PV‐1 expression in glomerular endothelial cells. In multivariable Cox models incorporating ΔPV‐1 and ΔC4d with clinical covariates, ΔPV‐1 remained independently associated with death‐censored graft survival, whereas ΔC4d did not.

Conclusions

Glomerular PV‐1 functions as a dynamic marker of endothelial remodelling that complements the static C4d footprint of complement activation. Combined assessment of PV‐1 and C4d captures distinct dimensions of microvascular pathology and may refine histopathological evaluation of injury and treatment response in caABMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionComplement C4bKidney TransplantationKidney GlomerulusPeptide FragmentsMembrane ProteinsHumansMaleFemaleMiddle AgedAdultBiomarkers

Stichwörter der Autor:innen

C4dPLVAP/PV‐1antibody‐mediated rejectionendothelial remodellingkidney transplantationtransplant glomerulopathy

Substanzen

Complement C4bcomplement C4dPeptide FragmentsPLVAP protein, humanBiomarkersMembrane Proteins

Autor:innen und Institutionen

  • Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Anatomy, Showa Medical University School of Medicine, Tokyo, Japan.
  • Internal Medicine (Nephrology), Showa Medical University Fujigaoka Hospital, Yokohama, Japan.
  • Department of Experimental Pathology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Division of Pathology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan.

ORCID-Profile: Yuto Igarashi, Mayu Shimokawa, Kunio Kawanishi, Toshihito Hirai, Hiroshi Seino, Tomokazu Shimizu, Hideki Ishida, Toshio Takagi

Förderung

  • Japan Science and Technology Agency

Zitieren

APA

Igarashi, Y., Shimokawa, M., Kawanishi, K., Hirai, T., Seino, H., Shimizu, T., Ishida, H., & Takagi, T. (2026). Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection. Histopathology, 89(2), 372-382. https://doi.org/10.1111/his.70162

Vancouver

Igarashi Y, Shimokawa M, Kawanishi K, Hirai T, Seino H, Shimizu T, et al. Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection. Histopathology. 2026;89(2):372-382. doi:10.1111/his.70162

BibTeX
@article{Igarashi2026,
  author = {Igarashi, Yuto and Shimokawa, Mayu and Kawanishi, Kunio and Hirai, Toshihito and Seino, Hiroshi and Shimizu, Tomokazu and Ishida, Hideki and Takagi, Toshio},
  title = {Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection},
  journal = {Histopathology},
  year = {2026},
  volume = {89},
  number = {2},
  pages = {372--382},
  doi = {10.1111/his.70162}
}
Kostenlos starten →